Can InsurTech Make Miracles in Health? By Amy Radin The winning business models for health insurers will be those that exhibit four crucial characteristics.
A Proposed Code of Conduct on Wellness By Al Lewis The C. Everett Koop Award just went to a company that HURT employees' health. It's time for a code of conduct for wellness programs.
Consumer-Friendly Healthcare Model By Stephen Ambrose Direct primary care (DPC) is a "hot knife" whose entry is well-timed to cut through the cold stick of butter called high healthcare costs.
New Healthcare Brawl, Different This Time By Stephen Ambrose Payers and health systems are blending in provider-sponsored organizations, driving toward integrated care in smaller pockets of populations.
A Heroin Vaccine -- Is It Possible? By Mark Pew The vaccine, which is being developed, "trains the immune system to usher the drugs out of the body before they can reach the brain."
Keep the Humanity in Healthcare By Stephen Ambrose Some may think the majority of patients just want their symptom or disease treated. News flash — you're wrong.
Medical Liability Insurance (Video) By Erik Leander Richard Anderson Society may debate whether "defensive medicine" exists -- but every doctor would tell you he practices it.
Hey, Pharma! It's Time for a Change By Stephen Ambrose Only half of pharmaceutical companies see consumerism as an opportunity. But that's EXACTLY where the growth lies.
Auto Insurance in an Existential Crisis By Stephen Applebaum Alan Demers The 125-year-old, $300 billion U.S. auto insurance industry is caught between runaway inflation and strained consumer wallets.
The Promise of Continuous Underwriting By Bill Deemer Bobby Touran Typically, a risk is underwritten, bound... and forgotten. But new streams of data and automation allow for continuous underwriting.
Convergence and the Insurance Ecosystem By Stephen Applebaum Alan Demers Companies must anticipate the future, innovate beyond their core and transform their capabilities as rapidly as technology allows.
Lemonade's 'Synthetic Agent' Nonsense By Matteo Carbone Desperate for growth, Lemonade produces another howler: A lender receiving a 16% interest rate is presented as a (synthetic) agent.